Generalizability of guidelines and physicians' adherence. Case study on the Sixth Joint National Commitee's guidelines on hypertension

Pedone, Claudio; Lapane, Kate L.
January 2003
BMC Public Health;2003, Vol. 3, p24
Academic Journal
Background: Clinical practice guidelines (CPG) are thought to be an effective tool in improving efficiency and outcomes of clinical practice. Physicians' adherence to guidelines is reported to be poor. We evaluated the relationship between generalizability of guidelines on hypertension and physicians' adherence to guidelines' recommendations for pharmacological treatment. Methods: We used the Sixth Joint National Committee's (JNC VI) guidelines on hypertension to evaluate our hypothesis. We evaluated the evidence from controlled clinical trials on which the JNC VI bases its recommendation, and compared the population enrolled in those trials with the American hypertensive population. Data on this population came from the National Health and Nutritional Examination Survey III. Results: Twenty-three percent of the NHANES population had a diagnosis of hypertension, 11% had hypertension requiring drug treatment according to the JNC VI. Only half of the population requiring treatment would have been enrolled in at least two trials. Rate of adherence to CPG was 69%. We found a weak association between generalizability and physicians' adherence to guidelines. Baseline risk was the major determinant of the decision to treat. Conclusion: JNC VI guidelines may not be generalizable to their target population. We found a relatively poor adherence rate to these guidelines. Failing of completely taking into account the clinical characteristics of the patients may be partly responsible for this lack of adherence.


Related Articles

  • Encouraging effective use of antihypertensives. Hardy, Sheila // Practice Nursing;Jul2009, Vol. 20 Issue 7, p342 

    The article examines the management of hypertension. Recommendations for managing hypertension in nonconcordant patients are included. The protocol for drug therapy as specified in the guidelines of the British Hypertension Society is provided. Reasons for patient noncompliance of treatment are...

  • Medical Management of Hypertension. Hutchinson, Richard G. // Angiology;Aug1979, Vol. 30 Issue 8, p558 

    In a paper like this, with such diverse information, it is impossible to summarize the content completely. Suffice it to say that a stepwise approach to the management of essential hypertension has been presented, beginning with a diuretic agent as the cornerstone of management for most...

  • Spin doctors soft pedal data on antihypertensives. Lenzer, Jeanne // BMJ: British Medical Journal (International Edition);1/18/2003, Vol. 326 Issue 7381, p170 

    Reports on the efforts of doctors to downplay findings in a study regarding the antihypertensive and lipid lowering to prevent heart attack trial (ALLHAT). How the study found that calcium channel blockers and angiotensin converting enzyme (ACE) inhibitors used to treat hypertension were no...

  • Thiazide use is defended by GPs in wake of ASCOT. Bowden, Rachel // GP: General Practitioner;11/11/2005, p11 

    The article reports on Great Britain general practitioners challenging plans to change the National Institute of Clinical Excellence hypertension guidelines following results from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). They have strongly defended the use of thiazides and...

  • Thiazide diuretics 'are best for hypertension'. Dragon, Natalie // GP: General Practitioner;1/6/2003, p4 

    Reports on the first line treatment for hypertension through thiazide diuretics recommended by U.S. researchers. Efficacy of thiazide diuretics in the prevention of cardiovascular diseases; Recommendation of beta-blockers and thiazide diuretics for the treatment of hypertension by the British...

  • CHOOSING THE BEST DIURETIC FOR HYPERTENSION. Mann, Samuel J. // Cortlandt Forum;5/25/2004, Vol. 17 Issue 5, p66 

    Presents question on choosing the best diuretic for hypertension.

  • Managing Hypertension with Combination Diuretics and Methyldopa in Nigerian Blacks at the Primary Care Level. Erhun, W.O.; Agbani, E.O.; Bolaji, E.E. // Clinical Drug Investigation;2003, Vol. 23 Issue 9, p583 

    Objective: To gain insight into the control of hypertension and to suggest possible interventions within a selected black population treated with combination diuretics (amiloride 5mg + hydrochlorothiazide 50mg) and/or methyldopa for uncomplicated essential hypertension. Design and setting: A...

  • TYPICAL ENTRY.  // MPR - Physician Assistants' Edition;Spring2015, Vol. 22 Issue 1, pA9 

    The article previews Demadex from pharmaceutical company Roche.

  • Choice of initial antihypertensive drugs and persistence of drug use-a 4-year follow-up of 78,453 incident users. Selmer, Randi; Blix, Hege; Landmark, Knud; Reikvam, Åsmund // European Journal of Clinical Pharmacology;Oct2012, Vol. 68 Issue 10, p1435 

    Purpose: To investigate patterns of initial drug therapy for the treatment of hypertension and to evaluate treatment persistence and change of treatment during a 4-year period in patients receiving thiazides (TZs) and/or angiotensin II-receptor blockers (ARBs) as first-line treatment. Methods:...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics